Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier BV in Molecular & Cellular Proteomics
- Vol. 18 (3), 437-447
- https://doi.org/10.1074/mcp.RA118.000957
Abstract
No abstract availableFunding Information
- HHS | National Institutes of Health (R01 CA210072, T32 ES018827)
This publication has 54 references indexed in Scilit:
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- Inflammasomes in carcinogenesis and anticancer immune responsesNature Immunology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- The genetic basis of kidney cancer: a metabolic diseaseNature Reviews Urology, 2010
- Epidemiology and risk factors for kidney cancerNature Reviews Urology, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Combinatorial patterns of histone acetylations and methylations in the human genomeNature Genetics, 2008